Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a 2-Month pill regimen beat TB in all forms?

NCT ID NCT06905522

Recruiting now Disease control Sponsor: Shenzhen Third People's Hospital Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 22 times

Summary

This study tests a new ultra-short treatment (2-3 months) for both drug-sensitive and drug-resistant active tuberculosis (TB). About 610 adults with confirmed TB will receive either the new regimen or standard care. The goal is to see if the shorter treatment works as well or better, with fewer side effects, and to find markers that predict success.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Chest Hospital of Capital Medical University

    RECRUITING

    Beijing, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Shenzhen Third People's Hospital

    RECRUITING

    Shenzhen, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • The Sixth People's Hospital of the Xinjiang Uygur Autonomous Region

    RECRUITING

    Ürümqi, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PULMONARY TUBERCULOSIS